In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diagnostic Products Corp.'s Contrarian Bet

Executive Summary

DPC has successfully transformed itself from a reagent to a systems company and carved out a niche in immunoassay systems, but has it gone as far as it can on its own in a consolidating industry that favors breadth of product lines across lab segments?
Advertisement

Related Content

With Pluck and Luck, Sysmex Tackles Hematology
Sysmex Bets on Best of Breed
Diagnostic Products Corp.: Thriving, For Now
Post Abbott Consent Decree; A Changed World for Immunoassay Vendors
Post Abbott Consent Decree; A Changed World for Immunoassay Vendors
An Intelligent Evolution for Dako and Cytomation
In Context: Aventis-Genta after Bristol-ImClone
An Intelligent Evolution for Dako and Cytomation

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel